Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychotropic Medication Use Before and During COVID-19: A Population-Wide Study
Christine Leong, Kaarina Kowalec, Sherif Eltonsy, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Occurrence and fate of antidepressants in the aquatic environment: Insights into toxicological effects on the aquatic life, analytical methods, and removal techniques
Adarsh Singh, Duduku Saidulu, Ashok Kumar Gupta, et al.
Journal of environmental chemical engineering (2022) Vol. 10, Iss. 6, pp. 109012-109012
Closed Access | Times Cited: 30
Utilization of antidepressants, anxiolytics, and hypnotics during the COVID-19 pandemic
Mikael Tiger, Giulio Castelpietra, Rikke Wesselhöeft, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Psychotropic consumption before and during COVID-19 in Asturias, Spain
María Luisa Nicieza García, Paula Fernández Martínez, Eva Fernández Bretón, et al.
BMC Public Health (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database
Renato de Filippis, John M. Kane, Elena Arzenton, et al.
Drug Safety (2024) Vol. 47, Iss. 8, pp. 745-757
Open Access | Times Cited: 5
On- and Off-Label Atypical Antipsychotic Prescription Trends Across a Nine-Year Period Among Adolescents Pre- to Post-COVID-19
Brianna Costales, Natalie E. Slama, Robert B. Penfold, et al.
Academic Pediatrics (2024) Vol. 24, Iss. 6, pp. 995-1000
Closed Access | Times Cited: 4
Adsorption of fluoxetine in aqueous environments: Development of macroporous cryogels based on sodium poly(acrylate) and carboxymethyl chitosan
Gilbert Romeo Nkana Nkana, Bruno Chabot, Phuong Nguyen‐Tri
Reactive and Functional Polymers (2024) Vol. 205, pp. 106069-106069
Closed Access | Times Cited: 4
Impact of COVID-19 on medical utilization for psychiatric conditions in Japan
Kazuhiro Abe, Kouta Suzuki, Atsushi Miyawaki, et al.
Social Science & Medicine (2025), pp. 117763-117763
Closed Access
A longitudinal cohort study on dispensed analgesic and psychotropic medications in older adults before, during, and after the COVID-19 pandemic: the HUNT study
Tanja Louise Ibsen, Ekaterina Zotcheva, Sverre Bergh, et al.
BMC Geriatrics (2025) Vol. 25, Iss. 1
Open Access
Fluctuations in dispensed out-patient psychotropic medication prescriptions during the COVID-19 pandemic in The Netherlands
D. Visser, Daphne Everaerd, Hannah Ellerbroek, et al.
BJPsych Open (2025) Vol. 11, Iss. 2
Open Access
Did the COVID-19 pandemic influence the use of psychotropic medications by university students and LGBTQIAPN+? A Brazilian multicenter study
Waléria de Paula, Adriana Lúcia Meireles, Bruna Carolina Rafael Barbosa, et al.
Cadernos de Saúde Pública (2025) Vol. 41, Iss. 3
Open Access
Trends in medication use during the COVID-19 pandemic in Quebec, Canada
Maude Gosselin, Marjolaine Dubé, Marc Simard, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
The Role of Psychobiotics to Ensure Mental Health during the COVID-19 Pandemic—A Current State of Knowledge
Dorota Zielińska, Marcelina Karbowiak, Aneta Brzezicka
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 17, pp. 11022-11022
Open Access | Times Cited: 18
Primary care visits due to mental health problems and use of psychotropic medication during the COVID-19 pandemic in Finnish adolescents and young adults
Ilari Kuitunen, Mikko Uimonen, Ville Ponkilainen, et al.
Child and Adolescent Psychiatry and Mental Health (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 8
Long-Acting Injectable Antipsychotics (LAIs) Prescribing Trends during the COVID-19 Pandemic in Romania
Ana Aliana Miron, Petru Ifteni, Andreea Teodorescu, et al.
Healthcare (2022) Vol. 10, Iss. 7, pp. 1265-1265
Open Access | Times Cited: 11
National trends in psychotropic medication prescribing before and during the COVID-19 pandemic
Molly Sanborn, Mir M. Ali, Timothy B. Creedon
Psychiatry Research (2023) Vol. 325, pp. 115248-115248
Open Access | Times Cited: 6
Patient demographics and psychotropic medication prescribing in Australian general practices: pre- and during COVID-19 pandemic
Getiye Dejenu Kibret, Abbish Kamalakkannan, Judith Thomas, et al.
Journal of Primary Health Care (2024) Vol. 16, Iss. 4, pp. 325-331
Open Access | Times Cited: 1
Public perception of psychiatry, psychology and mental health professionals: a 15-year analysis
Javier Domingo-Espiñeira, Andrea Varaona, María Montero-López Lena, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 1
Impact of the COVID-19 pandemic on psychotropic prescribing: a systematic review
Swettha Mahesarajah, Marie Line El Asmar, Ryan Irwin, et al.
BMJ Open (2024) Vol. 14, Iss. 9, pp. e076791-e076791
Open Access | Times Cited: 1
The Use of Psychotropic Medications Before and During the COVID-19 Pandemic and Its Associated Factors
Mohammed M. Alsultan
Journal of Clinical Medicine (2024) Vol. 13, Iss. 23, pp. 7419-7419
Open Access | Times Cited: 1
Depression, Suicidal Ideation, and Consumption of Psychotropic Drugs During Lockdown by COVID-19 According to Gender and Age
Víctor José Villanueva‐Blasco, Verónica Villanueva-Silvestre, Andrea Vázquez‐Martínez, et al.
International Journal of Mental Health and Addiction (2022) Vol. 22, Iss. 4, pp. 1859-1875
Open Access | Times Cited: 7
Prescription trends of antiseizure medications before and during the COVID-19 pandemic
Alekhya Lavu, Donica Janzen, Laila Aboulatta, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 3
Impact of the COVID-19 pandemic on the consumption patterns of psychotropic drugs and predictors of limited access to medication
Maya Rachidi, Georges Hatem, Melissa Hatem, et al.
The Journal of Medicine Access (2023) Vol. 7, pp. 275508342311637-275508342311637
Open Access | Times Cited: 2
Adherence to Psychotropic Medication Before and During COVID-19
Brandon Froese, G. B. Aquino, Eunice Valencia, et al.
Journal of Clinical Psychopharmacology (2023) Vol. 43, Iss. 4, pp. 313-319
Closed Access | Times Cited: 2
Impact of the COVID-19 pandemic on prescription drug use and costs in British Columbia: a retrospective interrupted time series study
Seraphine Zeitouny, Kimberlyn McGrail, Mina Tadrous, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e070031-e070031
Open Access
Impact of the COVID-19 Pandemic on the Use of Antidepressants by Young Adults in the ASL TO4 Regione Piemonte (Italy)
Lucrezia Greta Armando, Raffaella Baroetto Parisi, Cristina Rolando, et al.
Pharmacy (2024) Vol. 12, Iss. 1, pp. 21-21
Open Access
Page 1 - Next Page

Scroll to top